Humana Completes Divestiture of Majority Interest in Kindred at Home Hospice and Personal Care Divisions to CD&R

Humana Inc. announced on August 11, 2022 that it has successfully completed its previously-announced transaction with private investment firm Clayton, Dubilier & Rice (“CD&R”) to divest a majority interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home subsidiary (“KAH Hospice”). These divisions include patient-centered services for Hospice, Palliative, Community and Personal Care. Upon closing, the Hospice and Personal Care divisions have been restructured into a new standalone company.

“Humana will continue to support the long-term success of these operations through our minority ownership and ongoing strategic partnership,” said Susan Diamond, Chief Financial Officer of Humana. “Hospice and palliative services play an important role in the full continuum of care, and we are confident that this new standalone company will continue to provide patients and their families with the resources and high-quality care they need.”

“We are pleased to complete this transaction with Humana and CD&R. Our dedicated hospice and personal care company is focused on improving access, equity and quality of care for patients while remaining an employer of choice for health care professionals,” said David Causby, Chief Executive Officer of the new standalone company, soon to become Gentiva.